Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

TriSalus Life Sciences (TLSIW) Other Non-Current Assets (2022 - 2025)

TriSalus Life Sciences' Other Non-Current Assets history spans 4 years, with the latest figure at $418000.0 for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 1.18% year-over-year to $418000.0; the TTM value through Dec 2025 reached $418000.0, down 1.18%, while the annual FY2025 figure was $418000.0, 1.18% down from the prior year.
  • Other Non-Current Assets reached $418000.0 in Q4 2025 per TLSIW's latest filing, roughly flat from $419000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $466000.0 in Q4 2023 to a low of $367000.0 in Q4 2022.
  • Average Other Non-Current Assets over 4 years is $415909.1, with a median of $423000.0 recorded in 2024.
  • Peak YoY movement for Other Non-Current Assets: rose 26.98% in 2023, then fell 9.23% in 2024.
  • A 4-year view of Other Non-Current Assets shows it stood at $367000.0 in 2022, then increased by 26.98% to $466000.0 in 2023, then dropped by 9.23% to $423000.0 in 2024, then dropped by 1.18% to $418000.0 in 2025.
  • Per Business Quant, the three most recent readings for TLSIW's Other Non-Current Assets are $418000.0 (Q4 2025), $419000.0 (Q3 2025), and $419000.0 (Q2 2025).